» Articles » PMID: 25165189

Nephropathic Cystinosis: an International Consensus Document

Abstract

Cystinosis is caused by mutations in the CTNS gene (17p13.2), which encodes for a lysosomal cystine/proton symporter termed cystinosin. It is the most common cause of inherited renal Fanconi syndrome in young children. Because of its rarity, the diagnosis and specific treatment of cystinosis are frequently delayed, which has a significant impact on the overall prognosis. In this document, we have summarized expert opinions on several aspects of the disease to improve knowledge and provide guidance for diagnosis and treatment.

Citing Articles

Characteristics of Inherited Metabolic Disorders Following Kidney Transplantation: A 13-Year Observational Study.

Dickson K, Wu H, Sharma R, Stepien K, Jovanovic A, Chinnadurai R Medicina (Kaunas). 2024; 60(11).

PMID: 39596918 PMC: 11595874. DOI: 10.3390/medicina60111733.


Development and Evaluation of Different Electrospun Cysteamine-Loaded Nanofibrous Webs: A Promising Option for Treating a Rare Lysosomal Storage Disorder.

Omer S, Nagy N, Pinke B, Meszaros L, Kazsoki A, Zelko R Pharmaceutics. 2024; 16(8).

PMID: 39204398 PMC: 11360779. DOI: 10.3390/pharmaceutics16081052.


Ketogenic Diet and Progression of Kidney Disease in Animal Models of Nephropathic Cystinosis.

Bellomo F, Pugliese S, Cairoli S, Krohn P, De Stefanis C, Raso R J Am Soc Nephrol. 2024; 35(11):1493-1506.

PMID: 38995697 PMC: 11543012. DOI: 10.1681/ASN.0000000000000439.


Residual Cystine Transport Activity for Specific Infantile and Juvenile Mutations in a PTEC-Based Addback Model.

Medaer L, David D, Smits M, Levtchenko E, Sampaolesi M, Gijsbers R Cells. 2024; 13(7.

PMID: 38607085 PMC: 11011962. DOI: 10.3390/cells13070646.


Addressing the psychosocial aspects of transition to adult care in patients with cystinosis.

Stabouli S, Sommer A, Kraft S, Schweer K, Bethe D, Bertholet-Thomas A Pediatr Nephrol. 2024; 39(10):2861-2874.

PMID: 38517536 PMC: 11349776. DOI: 10.1007/s00467-024-06345-1.


References
1.
Kalatzis V, Nevo N, Cherqui S, Gasnier B, Antignac C . Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet. 2004; 13(13):1361-71. DOI: 10.1093/hmg/ddh152. View

2.
Kleta R, Bernardini I, Ueda M, Varade W, Phornphutkul C, Krasnewich D . Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr. 2004; 145(4):555-60. DOI: 10.1016/j.jpeds.2004.03.056. View

3.
Gahl W, Reed G, Thoene J, Schulman J, Rizzo W, Jonas A . Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987; 316(16):971-7. DOI: 10.1056/NEJM198704163161602. View

4.
Broyer M, Tete M, Gubler M . Late symptoms in infantile cystinosis. Pediatr Nephrol. 1987; 1(3):519-24. DOI: 10.1007/BF00849263. View

5.
van Stralen K, Emma F, Jager K, Verrina E, Schaefer F, Laube G . Improvement in the renal prognosis in nephropathic cystinosis. Clin J Am Soc Nephrol. 2011; 6(10):2485-91. PMC: 3359556. DOI: 10.2215/CJN.02000311. View